×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Sanara MedTech Inc. (SMTI) NASDAQ

$29.65 0.63 (2.17%)

Market Cap: $255.74M

As of 06/18/24 04:00 PM EDT. Market closed.

(SMTI)

Sanara MedTech Inc. (SMTI)
NASDAQ

$29.65
0.63 (2.17%)

Market Cap: $255.74M

As of 06/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

wound management technologies, inc., through its subsidiary, wound care innovations, llc, distributes collagen-based wound care products in the united states. the company holds worldwide license to certain technologies and processes related to a collagen-based wound care product formulation under the brand name celleraterx. it markets celleraterx for pressure ulcers, diabetic ulcers, surgical ... read more

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
1,500
Address
.
PRICE CHART FOR SANARA MEDTECH INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$28.57
Previous Close
$29.02
Days Range
$28.61 - $30.03
52 week range
$26.06 - $46.40
Volume
21,796
Avg. Volume (30 days)
20,624
Market Cap
$255.74M
Dividend Yield
-
P/E
-
Shares Outstanding
8,625,201
Open
$28.57
Previous Close
$29.02
Days Range
$28.61 - $30.03
52 week range
$26.06 - $46.40
Volume
21,796
Avg. Volume (30 days)
20,624
Market Cap
$255.74M
Dividend Yield
-
P/E
-
Shares Outstanding
8,625,201
FINANCIAL STATEMENTS FOR SANARA MEDTECH INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SANARA MEDTECH INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Fleming Zachary B.Chief Executive OfficerMar 01, 2024 Option Exercise$38.961,71666,85536,951Mar 05, 2024, 06:20 PM
Fleming Zachary B.Chief Executive OfficerFeb 01, 2024 Option Exercise$33.7242714,39837,877Feb 05, 2024, 06:29 PM
McNeil Michael D.Chief Financial OfficerFeb 01, 2024 Option Exercise$33.7239113,18522,634Feb 05, 2024, 06:27 PM
Fleming Zachary B.Chief Executive OfficerJan 01, 2024 Option Exercise$41.101,25551,58038,304Jan 03, 2024, 04:05 PM
Fleming Zachary B.Chief Executive OfficerSep 21, 2023 Option Exercise$37.1968425,43839,559Sep 22, 2023, 04:05 PM
McNeil Michael D.Chief Financial OfficerApr 12, 2023 Option Exercise$6.001,0006,00023,025Apr 14, 2023, 04:30 PM
Fleming Zachary B.Chief Executive OfficerMar 17, 2023 Option Exercise$41.052,955121,30442,097Mar 21, 2023, 04:15 PM
McMahon Rebecca EPresident - R&DMar 17, 2023 Option Exercise$41.502018,3429,595Mar 21, 2023, 04:15 PM
McNeil Michael D.Chief Financial OfficerMar 17, 2023 Option Exercise$41.361,44359,68222,810Mar 21, 2023, 04:15 PM
Fleming Zachary B.Chief Executive OfficerDec 02, 2022 Option Exercise$29.371,79652,75734,799Dec 06, 2022, 06:36 PM
Bowman Shawn M.Pres. - Strat. PartnershipsDec 02, 2022 Option Exercise$32.532,66786,76717,326Dec 06, 2022, 06:33 PM
McNeil Michael D.Chief Financial OfficerDec 02, 2022 Option Exercise$29.021,11832,44519,504Dec 06, 2022, 06:30 PM
Fleming Zachary B.Chief Executive OfficerNov 08, 2022 Sale$33.0041713,76136,270Nov 10, 2022, 04:10 PM
Fleming Zachary B.Chief Executive OfficerNov 04, 2022 Sale$33.0056318,57936,687Nov 08, 2022, 05:16 PM
Fleming Zachary B.Chief Executive OfficerNov 02, 2022 Sale$33.022066037,250Nov 04, 2022, 04:05 PM
Bowman Shawn M.Pres. - Strategic PartnershipsSep 22, 2022 Sale$27.891,00027,88718,890Sep 26, 2022, 05:00 PM
Fleming Zachary B.Chief Executive OfficerJul 06, 2022 Sale$22.531,41531,88038,020Jul 07, 2022, 05:18 PM
Fleming Zachary B.Chief Executive OfficerJul 05, 2022 Sale$21.452655,68438,685Jul 07, 2022, 05:18 PM
Fleming Zachary B.Chief Executive OfficerJun 28, 2022 Sale$21.00691,44939,244Jun 30, 2022, 04:56 PM
Fleming Zachary B.Chief Executive OfficerJun 29, 2022 Sale$21.002946,17438,950Jun 30, 2022, 04:56 PM
Fleming Zachary B.Chief Executive OfficerJun 24, 2022 Sale$21.004579,59739,313Jun 28, 2022, 04:05 PM
Bowman Shawn M.Pres. - Strategic PartnershipsJun 17, 2022 Sale$20.021,00020,02019,550Jun 21, 2022, 04:15 PM
Carmena J MichaelPrincipal Executive OfficerDec 31, 2020 Option Exercise$10.535465,74920,312Dec 20, 2021, 07:24 PM
Carmena J MichaelPrincipal Executive OfficerDec 16, 2021 Option Exercise$44.661,74878,06718,912Dec 20, 2021, 07:24 PM
Fleming Zachary B.President - Surgical Div.Dec 16, 2021 Option Exercise$43.0676232,81317,338Dec 20, 2021, 04:15 PM
McNeil Michael D.Chief Financial OfficerDec 16, 2021 Option Exercise$44.351,16851,80111,020Dec 20, 2021, 04:15 PM
Bowman Shawn M.President - Wound Care Div.Dec 16, 2021 Option Exercise$42.3459725,27815,545Dec 20, 2021, 04:15 PM
Fleming Zachary B.President - Surgical Div.Oct 26, 2021 Sale$34.041,00034,04017,708Oct 27, 2021, 04:22 PM
Bowman Shawn M.President - Wound Care Div.Oct 20, 2021 Sale$34.191,00034,19116,368Oct 21, 2021, 04:35 PM
Fleming Zachary B.President - Surgical Div.Oct 05, 2021 Sale$33.101,00033,10419,237Oct 07, 2021, 04:16 PM
Bowman Shawn M.President - Wound Care Div.Sep 28, 2021 Sale$33.331,00033,33016,668Sep 30, 2021, 05:09 PM
Carmena J MichaelPrincipal Executive OfficerSep 30, 2020 Option Exercise$10.531,09211,49919,766Oct 02, 2020, 06:49 PM
CGI Cellerate RX, LLC10% OwnerFeb 07, 2020 Option Exercise$9.00179,1011,611,9092,452,731Feb 11, 2020, 04:02 PM
Nixon Ronald TDirectorFeb 07, 2020 Option Exercise$9.00179,1011,611,9092,452,731Feb 10, 2020, 07:16 PM
Nixon Ronald TDirectorOct 15, 2019 Buy$8.30963,8568,000,005963,856Oct 17, 2019, 06:57 PM
STUCKERT JAMES WDirectorOct 15, 2019 Buy$8.30180,7231,500,001814,830Oct 17, 2019, 05:24 PM
HOWELL S ODEN JRDirectorOct 15, 2019 Buy$8.3060,241500,000481,165Oct 17, 2019, 05:20 PM
STUCKERT JAMES WDirectorFeb 19, 2018 Option Exercise$0.0724,362,7481,705,39265,094,503Jun 05, 2018, 07:01 PM
STUCKERT JAMES WDirectorFeb 19, 2018 Option Exercise$0.073,965,400277,5785,365,400Jun 05, 2018, 07:01 PM
HOWELL S ODEN JRDirectorFeb 27, 2018 Option Exercise$0.0719,817,1651,387,20242,092,429May 09, 2018, 08:04 PM
HOWELL S ODEN JRDirectorFeb 19, 2018 Option Exercise$0.0722,125,2641,548,76822,125,264May 09, 2018, 08:04 PM
HOWELL S ODEN JRDirectorMar 30, 2016 Buy$70.002,143150,0109,745Apr 20, 2016, 12:58 PM
STUCKERT JAMES WDirectorMar 30, 2016 Buy$70.002,143150,01036,384Apr 20, 2016, 12:51 PM
STUCKERT JAMES WDirectorDec 14, 2015 Buy$70.001,786125,0203,572Mar 28, 2016, 07:06 PM
HOWELL S ODEN JRDirectorDec 14, 2015 Buy$70.001,786125,0207,602Mar 28, 2016, 06:50 PM
STUCKERT JAMES W10% OwnerFeb 09, 2016 Buy$70.001,07174,9703,154Mar 10, 2016, 05:00 PM
HOWELL S ODEN JRDirectorFeb 09, 2016 Buy$70.001,07174,9704,030Mar 10, 2016, 04:53 PM
STUCKERT JAMES W10% OwnerFeb 09, 2016 Buy$70.001,07174,9704,030Mar 10, 2016, 04:46 PM
HOWELL S ODEN JRDirectorJul 31, 2015 Buy$69.991,786125,0004,745Sep 29, 2015, 10:48 AM
STUCKERT JAMES WDirectorJul 31, 2015 Buy$69.991,786125,0001,786Sep 29, 2015, 10:32 AM
COSSUTTA ARALDO ADirectorDec 22, 2008 Sale$3.256232,0255,268,091Jun 03, 2013, 04:33 PM
COSSUTTA ARALDO ADirectorDec 19, 2008 Sale$3.055001,5255,268,714Jun 03, 2013, 04:33 PM
COSSUTTA ARALDO ADirectorDec 16, 2008 Sale$3.255,00016,2505,269,214Jun 03, 2013, 04:33 PM
COSSUTTA ARALDO ADirectorDec 23, 2012 Sale$3.008,87726,6315,259,214Jun 03, 2013, 04:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Fleming Zachary B.Chief Executive Officer03/01/202466,855
Fleming Zachary B.Chief Executive Officer02/01/202414,398
McNeil Michael D.Chief Financial Officer02/01/202413,185
Fleming Zachary B.Chief Executive Officer01/01/202451,580
Fleming Zachary B.Chief Executive Officer09/21/202325,438
McNeil Michael D.Chief Financial Officer04/12/20236,000
Fleming Zachary B.Chief Executive Officer03/17/2023121,304
McMahon Rebecca EPresident - R&D03/17/20238,342
McNeil Michael D.Chief Financial Officer03/17/202359,682
Fleming Zachary B.Chief Executive Officer12/02/202252,757
Bowman Shawn M.Pres. - Strat. Partnerships12/02/202286,767
McNeil Michael D.Chief Financial Officer12/02/202232,445
Fleming Zachary B.Chief Executive Officer11/08/202213,761
Fleming Zachary B.Chief Executive Officer11/04/202218,579
Fleming Zachary B.Chief Executive Officer11/02/2022660
Bowman Shawn M.Pres. - Strategic Partnerships09/22/202227,887
Fleming Zachary B.Chief Executive Officer07/06/202231,880
Fleming Zachary B.Chief Executive Officer07/05/20225,684
Fleming Zachary B.Chief Executive Officer06/28/20221,449
Fleming Zachary B.Chief Executive Officer06/29/20226,174
Fleming Zachary B.Chief Executive Officer06/24/20229,597
Bowman Shawn M.Pres. - Strategic Partnerships06/17/202220,020
Carmena J MichaelPrincipal Executive Officer12/31/20205,749
Carmena J MichaelPrincipal Executive Officer12/16/202178,067
Fleming Zachary B.President - Surgical Div.12/16/202132,813
McNeil Michael D.Chief Financial Officer12/16/202151,801
Bowman Shawn M.President - Wound Care Div.12/16/202125,278
Fleming Zachary B.President - Surgical Div.10/26/202134,040
Bowman Shawn M.President - Wound Care Div.10/20/202134,191
Fleming Zachary B.President - Surgical Div.10/05/202133,104
Bowman Shawn M.President - Wound Care Div.09/28/202133,330
Carmena J MichaelPrincipal Executive Officer09/30/202011,499
CGI Cellerate RX, LLC10% Owner02/07/20201,611,909
Nixon Ronald TDirector02/07/20201,611,909
Nixon Ronald TDirector10/15/20198,000,005
STUCKERT JAMES WDirector10/15/20191,500,001
HOWELL S ODEN JRDirector10/15/2019500,000
STUCKERT JAMES WDirector02/19/20181,705,392
STUCKERT JAMES WDirector02/19/2018277,578
HOWELL S ODEN JRDirector02/27/20181,387,202
HOWELL S ODEN JRDirector02/19/20181,548,768
HOWELL S ODEN JRDirector03/30/2016150,010
STUCKERT JAMES WDirector03/30/2016150,010
STUCKERT JAMES WDirector12/14/2015125,020
HOWELL S ODEN JRDirector12/14/2015125,020
STUCKERT JAMES W10% Owner02/09/201674,970
HOWELL S ODEN JRDirector02/09/201674,970
STUCKERT JAMES W10% Owner02/09/201674,970
HOWELL S ODEN JRDirector07/31/2015125,000
STUCKERT JAMES WDirector07/31/2015125,000
COSSUTTA ARALDO ADirector12/22/20082,025
COSSUTTA ARALDO ADirector12/19/20081,525
COSSUTTA ARALDO ADirector12/16/200816,250
COSSUTTA ARALDO ADirector12/23/201226,631
Load More Insider Transactions
FUNDS WITH A POSITION IN SANARA MEDTECH INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.197,5870.00017%-3.5%Other
GEODE CAPITAL MANAGEMENT, LLC79,2950.00027%6.18%Other
RENAISSANCE TECHNOLOGIES LLC14,9000.00087%49%Other
CHANGE IN SHARES OUTSTANDING FOR SANARA MEDTECH INC
STOCK BUYBACKS FOR SANARA MEDTECH INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.44%
1Q
03/31/2024
09/30/2023
1.05%
2Q
03/31/2024
06/30/2023
2.35%
3Q
03/31/2024
03/31/2023
3.01%
4Q
03/31/2024
12/31/2022
3.73%
5Q
03/31/2024
09/30/2022
3.85%
6Q
03/31/2024
06/30/2022
3.14%
7Q
03/31/2024
03/31/2022
10.69%
8Q
03/31/2024
12/31/2021
11.85%
9Q
03/31/2024
09/30/2021
11.99%
10Q
03/31/2024
06/30/2021
12.31%
11Q
03/31/2024
03/31/2021
23.51%
12Q
03/31/2024
12/31/2020
46.52%
13Q
03/31/2024
09/30/2020
35.13%
14Q
03/31/2024
06/30/2020
35.72%
15Q
03/31/2024
03/31/2020
77.18%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.44%
1Q
09/30/2023
1.05%
2Q
06/30/2023
2.35%
3Q
03/31/2023
3.01%
4Q
12/31/2022
3.73%
5Q
09/30/2022
3.85%
6Q
06/30/2022
3.14%
7Q
03/31/2022
10.69%
8Q
12/31/2021
11.85%
9Q
09/30/2021
11.99%
10Q
06/30/2021
12.31%
11Q
03/31/2021
23.51%
12Q
12/31/2020
46.52%
13Q
09/30/2020
35.13%
14Q
06/30/2020
35.72%
15Q
03/31/2020
77.18%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SANARA MEDTECH INC
LOADING...